Nobivac Feline 1 HCPCH + FELV 25 X 1ds

Nobivac Feline 1 HCPCH + FELV  25 X 1ds
Nobivac Feline 1 HCPCH + FELV  25 X 1ds
View Images
  • There are no alternate images available for this product.
 

Nobivac Feline 1 HCPCH + FELV 25 X 1ds

  • Box Qty :

 

Product Description

 

NOBIVAC® Feline 1-HCPCh FeLV has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, panleukopenia, and feline leukemia viruses, as well as feline Chlamydophila. The duration of immunity against feline leukemia virus is at least 2 years. Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus. (Previously knowns as Chlamydia psittaci)
-Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses.1
-Subcutaneous or intramuscular injection
-Initial 1 mL dose administered at 9 weeks of age or older
-Second 1 mL dose administered 3 to 4 weeks later
-Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.
-Available in a 25 x 1 mL dose presentation

WARNINGS:
• Contains gentamicin and amphotericin B as preservatives.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following FeLV vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination may not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.

Close